Abound Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76K | Buy |
22
+4
| +22% | +$502 | ﹤0.01% | 700 |
|
|
2025
Q1 | $2.46K | Sell |
18
-3
| -14% | -$411 | ﹤0.01% | 668 |
|
|
2024
Q4 | $3.21K | Hold |
21
| – | – | ﹤0.01% | 613 |
|
|
2024
Q3 | $4.07K | Hold |
21
| – | – | ﹤0.01% | 585 |
|
|
2024
Q2 | $4.87K | Sell |
21
-2
| -9% | -$464 | ﹤0.01% | 506 |
|
|
2024
Q1 | $4.96K | Buy |
23
+6
| +35% | +$1.29K | ﹤0.01% | 523 |
|
|
2023
Q4 | $4.4K | Sell |
17
-8
| -32% | -$2.07K | ﹤0.01% | 539 |
|
|
2023
Q3 | $6.43K | Sell |
25
-4
| -14% | -$1.03K | ﹤0.01% | 411 |
|
|
2023
Q2 | $8.26K | Buy |
29
+4
| +16% | +$1.14K | ﹤0.01% | 379 |
|
|
2023
Q1 | $6.95K | Buy |
25
+9
| +56% | +$2.5K | ﹤0.01% | 341 |
|
|
2022
Q4 | $4.43K | Buy |
16
+9
| +129% | +$2.49K | ﹤0.01% | 372 |
|
|
2022
Q3 | $1.87K | Buy |
+7
| New | +$1.87K | ﹤0.01% | 493 |
|